We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

17 hedge funds and large institutions have $51.9K invested in Titan Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

452% more capital invested

Capital invested by funds: $9.41K → $51.9K (+$42.5K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

13% more funds holding

Funds holding: 15 → 17 (+2)

1.3% more ownership

Funds ownership: 0.32% → 1.62% (+1.3%)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$43.1K
2
CA
CoreCap Advisors
Michigan
+$317
3
BlackRock
BlackRock
New York
+$22
4
Bank of America
Bank of America
North Carolina
+$4
5
Morgan Stanley
Morgan Stanley
New York
+$4

Top Sellers

Rank Fund Capital Flow
1
MA
MCF Advisors
Kentucky
-$538
2
UBS Group
UBS Group
Switzerland
-$263
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$42.2K +$43.1K +11,961 New
UBS Group
2
UBS Group
Switzerland
$9.16K -$263 -73 -3%
CA
3
CoreCap Advisors
Michigan
$311 +$317 +88 New
Bank of America
4
Bank of America
North Carolina
$64 +$4 +1 +6%
Osaic Holdings
5
Osaic Holdings
Arizona
$49 – – –
Group One Trading
6
Group One Trading
Illinois
$42 – – –
BlackRock
7
BlackRock
New York
$21 +$22 +6 New
Morgan Stanley
8
Morgan Stanley
New York
$15 +$4 +1 +33%
GWSA
9
Global Wealth Strategies & Associates
Colorado
$7 – – –
CSC
10
Caldwell Sutter Capital
California
$4 – – –
CIA
11
Cape Investment Advisory
Georgia
$4 – – –
DJSG
12
D.J. St. Germain
Massachusetts
$4 – – –
NRG
13
Nemes Rush Group
Michigan
$4 – – –
RA
14
Ransom Advisory
Rhode Island
$4 – – –
SS
15
SBI Securities
Japan
$4 – – –
Wells Fargo
16
Wells Fargo
California
$4 – – –
WIM
17
Westside Investment Management
California
$4 – – –
MA
18
MCF Advisors
Kentucky
– -$538 -165 Closed

TTNP Hedge Fund Activity: Q1 2025 in Review

17 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q1 2025, worth a combined $51.9K — up 452% from $9.41K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TTNP positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $43.1K. The largest seller was MCF Advisors, exiting entirely with an estimated $538 sold.

  • 17 institutional investors held Titan Pharmaceuticals (TTNP) as of Q1 2025, up from 15 in Q4 2024.
  • Funds reported $51.9K of Titan Pharmaceuticals stock for Q1 2025, up 452% quarter-over-quarter.
  • 3 funds opened new Titan Pharmaceuticals positions in Q1 2025 and 1 closed out, a net change of +2 holders.
  • The largest Titan Pharmaceuticals buyer in Q1 2025 was Citadel Advisors, an estimated $43.1K added.
  • The largest Titan Pharmaceuticals seller in Q1 2025 was MCF Advisors, an estimated $538 sold.

Based on aggregated 13F filings for Q1 2025.